The first stop for professional medicines advice

Guidance

670 results

Applied filters

Understanding the characteristics of Spikevax (JN.1) vaccine

10 September 2024An overview of the Spikevax (JN.1) vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 30 (JN.1) vaccine

10 September 2024An overview of the Comirnaty 30 (JN.1) vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 10 (JN.1) ready to use vaccine

10 September 2024An overview of the Comirnaty 10 (JN.1) ready to use vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 3 (THREE) (JN.1) concentrate vaccine

10 September 2024An overview of the Comirnaty 3 (THREE) (JN.1) concentrate vaccine and signposts to other useful resources

Preparing Comirnaty 30 micrograms (JN.1) vaccine

10 September 2024An example SOP for preparing Comirnaty 30 micrograms (JN.1) vaccine

Preparing Comirnaty 10 (JN.1) ready to use vaccine

10 September 2024An example SOP for preparing Comirnaty 10 (JN.1) ready to use vaccine

Preparing Comirnaty 3 (THREE) (JN.1) concentrate vaccine

10 September 2024An example SOP for preparing Comirnaty 3 (THREE) (JN.1) concentrate vaccine

Preparing Spikevax (JN.1) vaccine

10 September 2024An example SOP for preparing Spikevax (JN.1) vaccine

Pharmacy Institutional Readiness for Exagamglogene Autotemcel (Casgevy®)

23 August 2024This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of Exagamglogene Autotemcel.

Treating acute hypokalaemia in adults

14 August 2024Untreated hypokalaemia (low potassium) can lead to life threatening arrhythmias. We guide on the safe management of potassium for acute hypokalaemia.